Regulation of brown fat by AMP-activated protein kinase

Trends in Molecular Medicine

Volumn 21, Issue 9, 2015, Pages 571-579

  van Dam, Andrea D ^a   Kooijman, Sander ^a   Schilperoort, Maaike ^a   Rensen, Patrick C N ^a   Boon, Mariëtte R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

AMP activated protein kinase; Brown adipose tissue; Energy expenditure; Hypothalamus; Thermogenesis; Uncoupling protein 1

Indexed keywords

BERBERINE; FATTY ACID; GALLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; METFORMIN; RESVERATROL; THIOCTIC ACID;

BROWN ADIPOCYTE; BROWN ADIPOSE TISSUE; CALORIC INTAKE; CELL ACTIVATION; CELL DIFFERENTIATION; COMBUSTION; ENERGY EXPENDITURE; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; GLUCOSE METABOLISM; HUMAN; HYPOTHALAMUS; LIPID METABOLISM; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; THERMOGENESIS; WHITE ADIPOSE TISSUE; ANIMAL; ENZYMOLOGY; GENETICS; METABOLISM; PATHOPHYSIOLOGY;

ADIPOSE TISSUE, BROWN; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; HUMANS; OBESITY; THERMOGENESIS;

EID: 84940584064     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2015.07.003     Document Type: Review

References (91)

1. Hill J.O., et al. Energy balance and obesity. Circulation 2012, 126:126-132.
2. Cypess A.M., et al. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 2009, 360:1509-1517.
3. van der Lans A.A., et al. Cold acclimation recruits human brown fat and increases nonshivering thermogenesis. J. Clin. Invest. 2013, 123:3395-3403.
4. Yoneshiro T., et al. Recruited brown adipose tissue as an antiobesity agent in humans. J. Clin. Invest. 2013, 123:3404-3408.
5. Blondin D.P., et al. Increased brown adipose tissue oxidative capacity in cold-acclimated humans. J. Clin. Endocrinol. Metab. 2014, 99:E438-E446.
6. Mulligan J.D., et al. Upregulation of AMPK during cold exposure occurs via distinct mechanisms in brown and white adipose tissue of the mouse. J. Physiol. 2007, 580:677-684.
7. Lopez M., et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat. Med. 2010, 16:1001-1008.
8. Whittle A.J., et al. BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell 2012, 149:871-885.
9. Martinez de Morentin P.B., et al. Nicotine induces negative energy balance through hypothalamic AMP-activated protein kinase. Diabetes 2012, 61:807-817.
10. Martinez de Morentin P.B., et al. Estradiol regulates brown adipose tissue thermogenesis via hypothalamic AMPK. Cell Metab. 2014, 20:41-53.
11. Hardie D.G. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int. J. Obes. (Lond.) 2008, 32(Suppl. 4):S7-S12.
12. Bijland S., et al. Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation. Clin. Sci. (Lond.) 2013, 124:491-507.
13. Steinberg G.R., Kemp B.E. AMPK in health and disease. Physiol. Rev. 2009, 89:1025-1078.
14. Woods A., et al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 2003, 13:2004-2008.
15. Hawley S.A., et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005, 2:9-19.
16. 2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005, 2:21-33.
17. 2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 2005, 280:29060-29066.
18. Viollet B., et al. Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J. Physiol. 2006, 574:41-53.
19. Kahn B.B., et al. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005, 1:15-25.
20. Jager S., et al. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:12017-12022.
21. Dzamko N.L., Steinberg G.R. AMPK-dependent hormonal regulation of whole-body energy metabolism. Acta Physiol. (Oxf.) 2009, 196:115-127.
22. Schneeberger M., Claret M. Recent insights into the role of hypothalamic AMPK signaling cascade upon metabolic control. Front. Neurosci. 2012, 6:185.
23. Marino J.S., et al. Central insulin and leptin-mediated autonomic control of glucose homeostasis. Trends Endocrinol. Metab. 2011, 22:275-285.
24. Yang C.S., et al. Hypothalamic AMP-activated protein kinase regulates glucose production. Diabetes 2010, 59:2435-2443.
25. Khedoe P.P., et al. Brown adipose tissue takes up plasma triglycerides mostly after lipolysis. J. Lipid Res. 2015, 56:51-59.
26. Cannon B., Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 2004, 84:277-359.
27. Lowell B.B., Spiegelman B.M. Towards a molecular understanding of adaptive thermogenesis. Nature 2000, 404:652-660.
28. Berbee J.F., et al. Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development. Nat. Commun. 2015, 6:6356.
29. Stanford K.I., et al. Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. J. Clin. Invest. 2013, 123:215-223.
30. van Marken Lichtenbelt W.D., et al. Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 2009, 360:1500-1508.
31. Vosselman M.J., et al. Energy dissipation in brown adipose tissue: from mice to men. Mol. Cell. Endocrinol. 2013, 379:43-50.
32. Wu J., et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 2012, 150:366-376.
33. Seale P., et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 2008, 454:961-967.
34. Lee P., et al. Functional thermogenic beige adipogenesis is inducible in human neck fat. Int. J. Obes. (Lond.) 2014, 38:170-176.
35. Cypess A.M., et al. Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat. Nat. Med. 2013, 19:635-639.
36. Parysow O., et al. Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans. Clin. Nucl. Med. 2007, 32:351-357.
37. Cypess A.M., et al. Activation of human brown adipose tissue by a β3-adrenergic receptor agonist. Cell Metab. 2015, 21:33-38.
38. Herwig A., et al. Hypothalamic thyroid hormone in energy balance regulation. Obes. Facts 2008, 1:71-79.
39. Mauvais-Jarvis F., et al. The role of estrogens in control of energy balance and glucose homeostasis. Endocr. Rev. 2013, 34:309-338.
40. Filozof C., et al. Smoking cessation and weight gain. Obes. Rev. 2004, 5:95-103.
41. Lahesmaa M., et al. Hyperthyroidism increases brown fat metabolism in humans. J. Clin. Endocrinol. Metab. 2014, 99:E28-E35.
42. Ziegler D., et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 1995, 38:1425-1433.
43. Kim M.S., et al. Anti-obesity effects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat. Med. 2004, 10:727-733.
44. Koh E.H., et al. Effects of α-lipoic acid on body weight in obese subjects. Am. J. Med. 2011, 124:85-88.
45. Lockie S.H., et al. Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling. Diabetes 2012, 61:2753-2762.
46. Seo S., et al. Acute effects of glucagon-like peptide-1 on hypothalamic neuropeptide and AMP activated kinase expression in fasted rats. Endocr. J. 2008, 55:867-874.
47. Beiroa D., et al. GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK. Diabetes 2014, 63:3346-3358.
48. Harder H., et al. The effect of liraglutide, a long-acting glucagon-like peptide 1 derivative, on glycemic control, body composition, and 24-h energy expenditure in patients with type 2 diabetes. Diabetes Care 2004, 27:1915-1921.
49. Horowitz M., et al. Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes. Diabetes Res. Clin. Pract. 2012, 97:258-266.
50. Medina-Gomez G., et al. Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARγ) and PPARγ coactivator-1 (PGC1). Public Health Nutr. 2007, 10:1132-1137.
51. Enriori P.J., et al. Leptin action in the dorsomedial hypothalamus increases sympathetic tone to brown adipose tissue in spite of systemic leptin resistance. J. Neurosci. 2011, 31:12189-12197.
52. Muller C., et al. Effect of chronic intracerebroventricular infusion of insulin on brown adipose tissue activity in fed and fasted rats. Int. J. Obes. Relat. Metab. Disord. 1997, 21:562-566.
53. Sakaue H., et al. Requirement for 3-phosphoinositide-dependent kinase-1 (PDK-1) in insulin-induced glucose uptake in immortalized brown adipocytes. J. Biol. Chem. 2003, 278:38870-38874.
54. Hutchinson D.S., et al. Beta-adrenoceptors, but not alpha-adrenoceptors, stimulate AMP-activated protein kinase in brown adipocytes independently of uncoupling protein-1. Diabetologia 2005, 48:2386-2395.
55. Vila-Bedmar R., et al. Adenosine 5'-monophosphate-activated protein kinase-mammalian target of rapamycin cross talk regulates brown adipocyte differentiation. Endocrinology 2010, 151:980-992.
56. Wan Z., et al. Evidence for the role of AMPK in regulating PGC-1 alpha expression and mitochondrial proteins in mouse epididymal adipose tissue. Obesity (Silver Spring) 2014, 22:730-738.
57. Xue B., et al. Transcriptional synergy and the regulation of Ucp1 during brown adipocyte induction in white fat depots. Mol. Cell. Biol. 2005, 25:8311-8322.
58. Geerling J.J., et al. Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice. Diabetes 2014, 63:880-891.
59. Zong H., et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:15983-15987.
60. Guigas B., et al. AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside. Biochem. J. 2007, 404:499-507.
61. Ahmadian M., et al. Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotype. Cell Metab. 2011, 13:739-748.
62. Anthony N.M., et al. Regulation of visceral and subcutaneous adipocyte lipolysis by acute AICAR-induced AMPK activation. Obesity (Silver Spring) 2009, 17:1312-1317.
63. Djouder N., et al. PKA phosphorylates and inactivates AMPKα to promote efficient lipolysis. EMBO J. 2010, 29:469-481.
64. An D., et al. The metabolic "switch" AMPK regulates cardiac heparin-releasable lipoprotein lipase. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E246-E253.
65. Luiken J.J., et al. Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 2003, 52:1627-1634.
66. Samovski D., et al. Insulin and AMPK regulate FA translocase/CD36 plasma membrane recruitment in cardiomyocytes via Rab GAP AS160 and Rab8a Rab GTPase. J. Lipid Res. 2012, 53:709-717.
67. Pulinilkunnil T., et al. Adrenergic regulation of AMP-activated protein kinase in brown adipose tissue in vivo. J. Biol. Chem. 2011, 286:8798-8809.
68. -/- mice. Am. J. Physiol Regul. Integr. Comp. Physiol. 2011, 301:R473-R483.
69. Villena J.A., et al. Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-α2 subunit. Diabetes 2004, 53:2242-2249.
70. Zhou Z., et al. Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat. Genet. 2003, 35:49-56.
71. Qi J., et al. Downregulation of AMP-activated protein kinase by Cidea-mediated ubiquitination and degradation in brown adipose tissue. EMBO J. 2008, 27:1537-1548.
72. Teperino R., et al. Hedgehog partial agonism drives Warburg-like metabolism in muscle and brown fat. Cell 2012, 151:414-426.
73. Yamauchi M., et al. Thyroid hormone activates adenosine 5'-monophosphate-activated protein kinase via intracellular calcium mobilization and activation of calcium/calmodulin-dependent protein kinase kinase-β. Mol. Endocrinol. 2008, 22:893-903.
74. Fritah A., et al. Absence of RIP140 reveals a pathway regulating glut4-dependent glucose uptake in oxidative skeletal muscle through UCP1-mediated activation of AMPK. PLoS ONE 2012, 7:e32520.
75. Treebak J.T., et al. AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes 2006, 55:2051-2058.
76. Matejkova O., et al. Possible involvement of AMP-activated protein kinase in obesity resistance induced by respiratory uncoupling in white fat. FEBS Lett. 2004, 569:245-248.
77. Schrauwen P., et al. Improved glucose homeostasis in mice overexpressing human UCP3: a role for AMP-kinase?. Int. J. Obes. Relat. Metab. Disord. 2004, 28:824-828.
78. Zhang Z., et al. Berberine activates thermogenesis in white and brown adipose tissue. Nat. Commun. 2014, 5:5493.
79. Doan K.V., et al. Gallic acid regulates body weight and glucose homeostasis through AMPK activation. Endocrinology 2015, 1:157-168.
80. Andrade J.M., et al. Resveratrol increases brown adipose tissue thermogenesis markers by increasing SIRT1 and energy expenditure and decreasing fat accumulation in adipose tissue of mice fed a standard diet. Eur. J. Nutr. 2014, 53:1503-1510.
81. Alberdi G., et al. Thermogenesis is involved in the body-fat lowering effects of resveratrol in rats. Food Chem. 2013, 141:1530-1535.
82. Um J.H., et al. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 2010, 59:554-563.
83. Golay A. Metformin and body weight. Int. J. Obes. (Lond.) 2008, 32:61-72.
84. Kahn S.E., et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N. Engl. J. Med. 2006, 355:2427-2443.
85. Yamanouchi T., et al. Comparison of metabolic effects of pioglitazone, metformin, and glimepiride over 1 year in Japanese patients with newly diagnosed type 2 diabetes. Diabet. Med. 2005, 22:980-985.
86. Salpeter S.R., et al. Meta-analysis: metformin treatment in persons at risk for diabetes mellitus. Am. J. Med. 2008, 121:149-157.
87. Minokoshi Y., Kahn B.B. Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle. Biochem. Soc. Trans. 2003, 31:196-201.
88. Krauss S., et al. The mitochondrial uncoupling-protein homologues. Nat. Rev. Mol. Cell Biol. 2005, 6:248-261.
89. Boon M.R., et al. [Brown adipose tissue: the body's own weapon against obesity?]. Ned. Tijdschr. Geneeskd. 2013, 157:A5502. (in Dutch).
90. Fedorenko A., et al. Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria. Cell 2012, 151:400-413.
91. Townsend K.L., Tseng Y.H. Brown fat fuel utilization and thermogenesis. Trends Endocrinol. Metab. 2014, 25:168-177.